Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

PURPOSE: To investigate the prognostic and predictive significance of subtyping node-positive early breast cancer by immunohistochemistry in a clinical trial of a docetaxel-containing regimen. METHODS: Pathologic data from a central laboratory were available for 1,350 patients (91%) from the BCIRG 0...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hugh, Judith, Hanson, John, Cheang, Maggie Chon U., Nielsen, Torsten O., Perou, Charles M., Dumontet, Charles, Reed, John, Krajewska, Maryla, Treilleux, Isabelle, Rupin, Matthieu, Magherini, Emmanuelle, Mackey, John, Martin, Miguel, Vogel, Charles
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: American Society of Clinical Oncology 2009
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2667821/
https://ncbi.nlm.nih.gov/pubmed/19204205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.1024
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
Byddwch y cyntaf i adael sylw!
Rhaid i chi fewngofnodi yn gyntaf

Eitemau Tebyg